Moreover, a recent study showed that C66 predominantly targeted JNK2, as both Jnk2 gene deletion and C66 treatment could similarly activate NRF2 and alleviate diabetes‐induced aortic oxidative stress, inflammation and fibrosis.43 Here, NFE2L2 is linked to diabetes mellitus.